Search research articles
Contact Us
Filters
Showing results (341-350 of 362) with videos related to
Page
of 37
Sort By:
European Journal of Medicinal Chemistry
|
December 10, 2014
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme
Julie Charton, Marion Gauriot, Jane Totobenazara, et al.
JCI Insight
|
April 8, 2026
JAK inhibition may prevent drug hypersensitivity reactions
Xiangmei Hua, Pranali N Shah, Gustavo A Velasquez, et al.
Nature Communications
|
April 23, 2026
In silico discovery of nanobody binders to a G-protein coupled receptor using AlphaFold-Multimer
Edward P Harvey, Jeffrey S Smith, Joseph D Hurley, et al.
Elife
|
March 30, 2018
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
Zhening Zhang, Wenguang G Liang, Lucas J Bailey, et al.
AJNR. American Journal of Neuroradiology
|
March 31, 2018
Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT)
J-M Liu, Y Zhou, Y Li, et al.
Nature Communications
|
March 2, 2021
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G Liang, Danmei Su, Tian-Zhang Song, et al.
Journal of the American College of Radiology : JACR
|
June 1, 2024
ACR Appropriateness Criteria® Soft Tissue Vascular Anomalies: Vascular Malformations and Infantile Vascular Tumors (Non-CNS)-Child
, Dianna M E Bardo, Anne E Gill, et al.
The Journal of Clinical Investigation
|
July 23, 2024
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets
Pranali N Shah, George A Romar, Artür Manukyan, et al.
Circulation
|
July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome
Leslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
The American Journal of Surgical Pathology
|
April 6, 2022
Kaposiform Lymphangiomatosis: Pathologic Aspects in 43 Patients
Antonio R Perez-Atayde, Larisa Debelenko, Alyaa Al-Ibraheemi, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 362) with videos related to
Sort By:
Page
of 37
European Journal of Medicinal Chemistry
|
December 10, 2014
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme
Julie Charton, Marion Gauriot, Jane Totobenazara, et al.
JCI Insight
|
April 8, 2026
JAK inhibition may prevent drug hypersensitivity reactions
Xiangmei Hua, Pranali N Shah, Gustavo A Velasquez, et al.
Nature Communications
|
April 23, 2026
In silico discovery of nanobody binders to a G-protein coupled receptor using AlphaFold-Multimer
Edward P Harvey, Jeffrey S Smith, Joseph D Hurley, et al.
Elife
|
March 30, 2018
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
Zhening Zhang, Wenguang G Liang, Lucas J Bailey, et al.
AJNR. American Journal of Neuroradiology
|
March 31, 2018
Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT)
J-M Liu, Y Zhou, Y Li, et al.
Nature Communications
|
March 2, 2021
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G Liang, Danmei Su, Tian-Zhang Song, et al.
Journal of the American College of Radiology : JACR
|
June 1, 2024
ACR Appropriateness Criteria® Soft Tissue Vascular Anomalies: Vascular Malformations and Infantile Vascular Tumors (Non-CNS)-Child
, Dianna M E Bardo, Anne E Gill, et al.
The Journal of Clinical Investigation
|
July 23, 2024
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets
Pranali N Shah, George A Romar, Artür Manukyan, et al.
Circulation
|
July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome
Leslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
The American Journal of Surgical Pathology
|
April 6, 2022
Kaposiform Lymphangiomatosis: Pathologic Aspects in 43 Patients
Antonio R Perez-Atayde, Larisa Debelenko, Alyaa Al-Ibraheemi, et al.
Page
of 37